Atellica IM BRAHMS Procalcitonin (PCT)
Device To Detect And Measure Procalcitonin (Pct) In Human Clinical Specimens. 510(k) K181002, from Siemens Healthcare Diagnostics, Inc. (Tarrytown, NY). Product code PMT, class 2.
As of Nov 20, 2026, K181002 is an FDA 510(k) held by Siemens Healthcare Diagnostics, Inc., substantially equivalent on Jul 16, 2018 after 91 days, with no recalls tied to it in FDA's recall database.
- Review time: 91 days
- Recalls: 0
The Atellica® IM BRAHMS Procalcitonin (PCT) assay is for in vitro diagnostic use in the quantitative determination of procalcitonin in human serum and plasma (EDTA, lithium heparin, and sodium heparin) using the Atellica® IM Analyzer.
- B.R.A.H.M.S PCT sensitive KRYPTORDEN150009 · Brahms GmbH · Feb 20, 2016
- B R A H M S PCT sensitive KRYPTORK171338 · Brahms GmbH · May 31, 2017
- Document
- 510(k) summary (PDF) ↗
- Type
- Traditional
- Received
- Apr 16, 2018
- Review panel
- Microbiology
- Regulation
- 21 CFR 866.3215
One page per 510(k), De Novo and original PMA. Recalls are those FDA's recall database ties to this number; recalls of related devices that cite another number are not shown. Refreshed weekly. Predicates are read by Arca from the text of FDA's 510(k) summary PDFs, most of them scans: a device number counts when the summary names it as a predicate or as the device it is substantially equivalent to. About 97% of those read were right on a sample we checked by hand; summaries from before 2000 often name predicates without a number, so older devices show fewer. Pivotal studies are read by a model from FDA's De Novo decision summaries and PMA SSEDs; a count or result is shown only when its numbers appear in FDA's text. openFDA device 510(k), PMA and recall files